UTILITY therapeutics Ltd.是一家专注于在美国开发和商业化两种欧洲批准用于治疗尿路感染（UTI）的抗生素的生物技术公司，该公司近日宣布获得由AMR行动基金（AMR Action Fund）领投的私募融资。此外，UTILITY 还宣布美国食品和药物管理局 (FDA) 已受理其用于治疗无并发症尿路感染 (uUTI) 的 PIVYA（匹美西林泮）新药...
e2 最近宣布与 Nabors Industries Ltd. (“Nabors”) 达成战略合作,将 e2 的综合电力解决方案引入油田和更广泛的能源市场。 此次交易预计将为新上市公司带来约 4 亿美元的总收益,其中包括 Nabors Energy Transition Corp. II (“NETD”) 信托账户中持有的约 3.31 亿美元现金(在考虑潜在赎回之前)以及 NETD 普通股...
LINKED CONTENT: This article is linked to Hagstrom et al paper. To view this article, visit https://doi.org/10.1111/apt.17374doi:10.1111/apt.17459Lai, RongtaoNguyen, Mindie H.John Wiley & Sons, Ltd.Alimentary Pharmacology & Therapeutics...
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut … The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018...
Dove Press Ltd.Therapeutics & Clinical Risk ManagementCaccia S, Invernizzi RW, Nobili A, Pasina L (2013) A new generation of antipsychotics: pharmacology ... S Caccia,RW Invernizzi,A Nobili,... - 《Therapeutics & Clinical Risk Management》 被引量: 38发表: 2013年 Acamprosate for treatment of...
Dove Press Ltd.Therapeutics & Clinical Risk ManagementAikawa N, Kawasaki Y. Clinical utility of the neutrophil elastase inhibitor sivelestat for the treatment... Y Kawasaki,N Aikawa - 《Therapeutics & Clinical Risk Management》 被引量: 26发表: 2014年 The cost-effectiveness of a NSCLC patient ass...
[13–16]. The utility of NSAIDs in the cancer therapeutics is not limited to prevention strategies. The NSAID sulindac has been shown to cause regression of colorectal adenomas of patients with hereditary forms of polyposis (Familial Adenomatous Polyposis (FAP) and Gardner's Syndrome) [17–19]...
Sánchez-Fueyo are founders of Quell Therapeutics Ltd and Marc Martinez-Llordella is currently employed by Quell Therapeutics. The other authors of this manuscript have no conflicts of interest to disclose as described by the American Journal of Transplantation. Acknowledgments The authors are grateful ...
2011, Clinical Therapeutics more Hazel Squires, Paul Tappenden, Katy Cooper, Christopher Carroll, Richard Logan, Daniel Hind Cost-Effectiveness of Aspirin, Celecoxib, and Calcium Chemoprevention for Colorectal Cancer Clinical Therapeutics, Volume 33, Issue 9, September 2011, Pages 1289–1305 Original Res...
- 《Alimentary Pharmacology & Therapeutics》 被引量: 86发表: 2012年 Systematic review: antibodies and anti-TNF-α levels in inflammatory bowel disease. SummaryBackgroundThe associations between clinical efficacy and infusion reactions with anti-TNF- drug levels and the presence of antibodies against ...